BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15385135)

  • 1. Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California.
    Mills PK; Riordan DG; Cress RD
    Gynecol Oncol; 2004 Oct; 95(1):215-25. PubMed ID: 15385135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of pregnancy and the risk of epithelial ovarian cancer.
    Whiteman DC; Siskind V; Purdie DM; Green AC
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond parity: association of ovarian cancer with length of gestation and offspring characteristics.
    Jordan SJ; Green AC; Nagle CM; Olsen CM; Whiteman DC; Webb PM; ;
    Am J Epidemiol; 2009 Sep; 170(5):607-14. PubMed ID: 19638480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthropometry and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Ness RB; Allen GO
    Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
    Jordan SJ; Green AC; Whiteman DC; Webb PM;
    Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.
    Soegaard M; Jensen A; Høgdall E; Christensen L; Høgdall C; Blaakaer J; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1160-6. PubMed ID: 17548679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk.
    Mills PK; Riordan DG; Cress RD; Goldsmith DF
    Cancer Detect Prev; 2005; 29(2):124-32. PubMed ID: 15829372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
    Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
    Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for benign serous and mucinous epithelial ovarian tumors.
    Jordan SJ; Green AC; Whiteman DC; Webb PM
    Obstet Gynecol; 2007 Mar; 109(3):647-54. PubMed ID: 17329516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of renal cell carcinoma subsequent to hysterectomy.
    Gago-Dominguez M; Castelao JE; Yuan JM; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):999-1003. PubMed ID: 10566555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender of offspring and maternal risk of invasive epithelial ovarian cancer.
    Baik I; Lambe M; Liu Q; Cnattingius S; Mucci LA; Riman T; Ekbom A; Adami HO; Hsieh CC
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2314-20. PubMed ID: 18006920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer.
    Eltabbakh GH; Natarajan N; Piver MS; Mettlin CJ
    Gynecol Oncol; 1999 Jul; 74(1):103-7. PubMed ID: 10385559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic types of epithelial ovarian cancer: have they different risk factors?
    Kurian AW; Balise RR; McGuire V; Whittemore AS
    Gynecol Oncol; 2005 Feb; 96(2):520-30. PubMed ID: 15661246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of California.
    Mills PK; Riordan DG; Cress RD; Young HA
    Int J Cancer; 2004 Nov; 112(3):458-64. PubMed ID: 15382072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breastfeeding and risk of epithelial ovarian cancer.
    Jordan SJ; Siskind V; C Green A; Whiteman DC; Webb PM
    Cancer Causes Control; 2010 Jan; 21(1):109-16. PubMed ID: 19779839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Allen GO; Ness RB
    Obstet Gynecol; 2005 Apr; 105(4):731-40. PubMed ID: 15802398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intake of specific carotenoids and the risk of epithelial ovarian cancer.
    Zhang M; Holman CD; Binns CW
    Br J Nutr; 2007 Jul; 98(1):187-93. PubMed ID: 17367574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.